Rating History for Stemline Therapeutics (STML) by H.C. Wainwright

More Stocks Rated by H.C. Wainwright | Latest Ratings for STML
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/5/2020 Raghuram Selvaraju Downgrade Neutral
(Buy)		 12.50
(N/A)		 12.11
(11.83)		 -2.31% Details